Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Hackensack Meridian Health
University of Chicago
St. Jude Children's Research Hospital
Baptist Health South Florida
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
City of Hope Medical Center
St. Jude Children's Research Hospital
Roswell Park Cancer Institute
St. Jude Children's Research Hospital
University of Illinois at Chicago
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
St. Jude Children's Research Hospital
Children's Hospital Medical Center, Cincinnati
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Dana-Farber Cancer Institute
Therapeutic Advances in Childhood Leukemia Consortium
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
Massachusetts General Hospital
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
University of Illinois at Chicago
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Northwestern University
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Stanford University
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Baptist Health South Florida
Dana-Farber Cancer Institute
University of Pittsburgh